TrakCel use technology to safely connect patients to advanced therapies by designing, deploying, and supporting digital Cellular Orchestration Platforms (COP) for Cell and Gene Therapy (CGT) developers.

TrakCel’s flagship COP, OCELLOS helps developers manage complex CGT supply chains from clinical trial to commercialization, ensuring that therapies reach patients quickly, safely, and in line with quality and regulatory requirements. OCELLOS can manage most types of cell or gene therapy, safeguarding patient data security, whilst monitoring and tracking each therapy journey.
For personalized CGT therapies OCELLOS tracks the Chain of Identity across all steps of the supply chain, ensuring the therapy can only be administered to the patient it was made for, preventing errors that could cause a dangerous, potentially fatal adverse reaction.

OCELLOS also tracks and monitors Chain of Custody (where a therapy is in the supply chain and who is responsible for it) for live cells within the supply chain, automating process steps to speed up progress and flag and prevent errors that could result in an unusable therapy. The system prompts users to perform vital quality checks at critical points in the supply chain keeping a searchable audit log of the results as well as streamlining administrative processes.